Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
Derek A. Oldridge(California University of Pennsylvania), John M. Maris(Children's Hospital of Philadelphia), Lori S. Hart(Wake Forest University), Cynthia Winter(Children's Hospital of Philadelphia), Nina Weichert‐Leahey(Dana-Farber Cancer Institute), Robyn T. Sussman(University of Pennsylvania), Javed Khan(Kent State University), Achille Iolascon(Ceinge Biotecnologie Avanzate (Italy)), Maura Diamond(Children's Hospital of Philadelphia), Lars Anders(Pfizer (United States)), Brian J. Abraham(Whitehead Institute for Biomedical Research), Jaime M. Guidry Auvil(National Institutes of Health), Jun S. Wei(Center for Cancer Research), Shile Zhang(Guardant (United States)), Adam D. Durbin(St. Jude Children's Research Hospital), Shizhen Zhu(Mayo Clinic), Sharon J. Diskin(Children's Hospital of Philadelphia), Mario Capasso(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)), Andrew Wood(University of Auckland), Lifeng Tian(Children's Hospital of Philadelphia), A. Thomas Look(Dana-Farber Cancer Institute), Håkon Håkonarson(Children's Hospital of Philadelphia), Nazneen Rahman(Institute of Cancer Research), Richard A. Young(Whitehead Institute for Biomedical Research), Kelli Bramlett(Eli Lilly (United States)), Lee McDaniel(Children's Hospital of Philadelphia), Daniela S. Gerhard(United States Department of Health and Human Services), Ian Crimmins(Children's Hospital of Philadelphia)
Cited by 303
Related Papers
The MicroRNA Spectrum in 12 Body Fluids
|Clinical Chemistry|2010|2.8k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Analysis of shared heritability in common disorders of the brain
|Science|2018|2k